Take Care Team Connect, an Evanston, Ill.-based IT firm that provides software platforms for population healthcare management while also offering provider coaching services on how to manage population-based workflows effectively.
BioMaryland is supporting various events in France which benefit the biohealth community. See if your company qualifies for a travel assistance grant to fly out and attend!
Hospital executives have never been frivolous when it comes to investing in technology, but as reimbursements shrink, the need to carefully analyze each purchasing decision has never been more urgent. Given all the worthwhile – and not so worthwhile – options, what choices are hospital administrators currently making?
Washington: A group of researchers have made a significant breakthrough for figuring out which mutations are benign and which are deleterious in cystic fibrosis.
This summer marked the inauguration of the DreamIt Health accelerator, a startup boot camp focused on healthcare IT run by DreamIt Ventures and powered by Penn Medicine and Independence Blue Cross. In four short months, ten extraordinary teams of entrepreneurs, including four from Wharton, were brought together from around the country to achieve significant milestones going from concepts to prototypes, products, pilots and revenues. As the program wound down, the investor, startup and healthcare community turned out in force for Demo Day to see a snapshot of each company’s progress and plans for the future.
AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a definitive agreement to acquire Amplimmune, a privately-held, Maryland, US-based biologics company focused on developing novel therapeutics in cancer immunology.
Hospital executives have never been frivolous when it comes to investing in technology, but as reimbursements shrink, the need to carefully analyze each purchasing decision has never been more urgent.
Given all the worthwhile – and not so worthwhile – options, what choices are hospital administrators currently making?
Since IT spending is largely taken up by meeting meaningful use and ICD-10 requirements, said Chantal Worzala, director of policy at the American Hospital Association, hospitals don’t have much left over for investments in other things.
Capital expenditure per bed for IT grew by 62 percent between 2010 and 2011, Worzala said, whereas total capital expenditure per bed grew by only 2.6 percent.
Image Courtesy of photostock / FreeDigitalPhotos.net
This summer marked the inauguration of the DreamIt Health accelerator, a startup boot camp focused on healthcare IT run by DreamIt Ventures and powered by Penn Medicine and Independence Blue Cross. In four short months, ten extraordinary teams of entrepreneurs, including four from Wharton, were brought together from around the country to achieve significant milestones going from concepts to prototypes, products, pilots and revenues. As the program wound down, the investor, startup and healthcare community turned out in force for Demo Day to see a snapshot of each company’s progress and plans for the future.
Free Program Helps Researchers Explore the Commercial Potential of Technologies
The DC National Science Foundation (NSF) Innovation Corps (I-Corps) program is now accepting applications for its October cohort.
Open to research teams and technology entrepreneurs from universities, federal laboratories, agencies and the general community in the Mid-Atlantic Region, the free program guides researchers in exploring the commercial potential of their inventions.
“I-Corps provides real world, hands-on training on how to successfully incorporate innovations into successful products,” said DC I-Corps Director Edmund Pendleton. “The ultimate goal is to create a new venture or licensing opportunity for program participants.”
Richard Moore, BD DiagnosticsROCKVILLE AND BALTIMORE, MARYLAND, August 26, 2013 – BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today its selection of Richard Moore, M.D., Ph.D., as a new Entrepreneur-in-Residence (EIR) at the National Institutes of Health (NIH) Office of Technology Transfer (OTT). BHI and BD established this position in July 2013. Dr. Moore, an executive with decades of experience in diagnostics development and technology strategy, will help support the development of new start-up companies and product commercialization based upon innovative technologies selected via OTT license agreements.